Analysis of MEF2C immunoreactivity showed a 24% increase in MEF2C expression/tumor area in metastasis throughout time, between 3 and 10 days (P < 0.01) and a 20% elevation between 7 and 10 days (P < 0.01) (Fig. 5C). Here, MEF2C is linked to neoplasm.